hydrogen sulfide has been researched along with Glaucoma in 11 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glaucoma is an optic neuropathy disorder marked by progressive degeneration of the retinal ganglion cells (RGC)." | 6.82 | Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies. ( Mhatre, S; Opere, CA; Singh, S, 2022) |
| "Glaucoma is a neurodegenerative disease of visual system characterized by gradual loss of retinal ganglion cells (RGC)." | 5.72 | Hydrogen sulfide supplement preserves mitochondrial function of retinal ganglion cell in a rat glaucoma model. ( Chen, J; Huang, P; Huang, S; Liu, X; Shen, X; Wang, J; Yu, H; Zhong, Y, 2022) |
| "Glaucoma is a neurodegenerative eye disease characterized by gradually impaired visual field and irreversible blindness due to retinal ganglion cell (RGC) loss." | 5.51 | Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma. ( Guo, L; Huang, P; Huang, S; Lin, Z; Liu, X; Shen, X; Yu, H; Zhong, Y, 2019) |
| "Glaucoma is a group of neurodegenerative eye diseases characterized by progressive impairment of visual function due to loss of retinal ganglion cells (RGC)." | 5.48 | Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma. ( Guo, L; Huang, P; Huang, S; Li, C; Lin, Z; Liu, X; Shen, X; Xu, X; Zhong, Y, 2018) |
| "Glaucoma is an irreversible and blinding neurodegenerative disease of the eye, and is characterized by progressive loss of retinal ganglion cells (RGCs)." | 5.46 | Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model. ( Guo, L; Huang, P; Huang, S; Leung, CK; Lin, Z; Liu, X; Wang, J; Xu, S; Zhong, Y, 2017) |
| "A hydrogen sulphide-releasing derivative of latanoprost acid (ACS 67) was synthesized and tested in vivo to evaluate its activity on reduction of intraocular pressure and tolerability." | 3.75 | New prostaglandin derivative for glaucoma treatment. ( Lanzi, C; Masini, E; Perrino, E; Soldato, PD; Sparatore, A; Uliva, C, 2009) |
| "Glaucoma is an optic neuropathy disorder marked by progressive degeneration of the retinal ganglion cells (RGC)." | 2.82 | Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies. ( Mhatre, S; Opere, CA; Singh, S, 2022) |
| "Glaucoma is a neurodegenerative disease of visual system characterized by gradual loss of retinal ganglion cells (RGC)." | 1.72 | Hydrogen sulfide supplement preserves mitochondrial function of retinal ganglion cell in a rat glaucoma model. ( Chen, J; Huang, P; Huang, S; Liu, X; Shen, X; Wang, J; Yu, H; Zhong, Y, 2022) |
| "Glaucoma is a group of eye diseases consisting of optic nerve damage with corresponding loss of field vision and blindness." | 1.72 | Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H ( Andreozzi, G; Calderone, V; Caliendo, G; Citi, V; Corvino, A; Fiorino, F; Frecentese, F; Magli, E; Martelli, A; Perissutti, E; Piragine, E; Santagada, V; Severino, B; Sparaco, R, 2022) |
| "Glaucoma is a neurodegenerative eye disease characterized by gradually impaired visual field and irreversible blindness due to retinal ganglion cell (RGC) loss." | 1.51 | Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma. ( Guo, L; Huang, P; Huang, S; Lin, Z; Liu, X; Shen, X; Yu, H; Zhong, Y, 2019) |
| "Glaucoma is a group of neurodegenerative eye diseases characterized by progressive impairment of visual function due to loss of retinal ganglion cells (RGC)." | 1.48 | Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma. ( Guo, L; Huang, P; Huang, S; Li, C; Lin, Z; Liu, X; Shen, X; Xu, X; Zhong, Y, 2018) |
| "Glaucoma is an irreversible and blinding neurodegenerative disease of the eye, and is characterized by progressive loss of retinal ganglion cells (RGCs)." | 1.46 | Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model. ( Guo, L; Huang, P; Huang, S; Leung, CK; Lin, Z; Liu, X; Wang, J; Xu, S; Zhong, Y, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Mhatre, S | 1 |
| Opere, CA | 1 |
| Singh, S | 1 |
| Huang, S | 5 |
| Huang, P | 5 |
| Yu, H | 3 |
| Chen, J | 1 |
| Liu, X | 4 |
| Wang, J | 2 |
| Shen, X | 3 |
| Zhong, Y | 5 |
| Sparaco, R | 3 |
| Citi, V | 3 |
| Magli, E | 3 |
| Martelli, A | 3 |
| Piragine, E | 3 |
| Calderone, V | 3 |
| Andreozzi, G | 3 |
| Perissutti, E | 3 |
| Frecentese, F | 3 |
| Santagada, V | 3 |
| Caliendo, G | 3 |
| Severino, B | 3 |
| Corvino, A | 3 |
| Fiorino, F | 3 |
| Lin, Z | 4 |
| Guo, L | 3 |
| Sun, J | 1 |
| Liu, H | 1 |
| Anders, F | 1 |
| Thanos, S | 1 |
| Mann, C | 1 |
| Liu, A | 1 |
| Grus, FH | 1 |
| Pfeiffer, N | 1 |
| Prokosch-Willing, V | 1 |
| Xu, X | 1 |
| Li, C | 1 |
| Han, Y | 1 |
| Shang, Q | 1 |
| Yao, J | 1 |
| Ji, Y | 1 |
| Xu, S | 1 |
| Leung, CK | 1 |
| Perrino, E | 1 |
| Uliva, C | 1 |
| Lanzi, C | 1 |
| Soldato, PD | 1 |
| Masini, E | 1 |
| Sparatore, A | 1 |
| Bucolo, C | 1 |
| Drago, F | 1 |
3 reviews available for hydrogen sulfide and Glaucoma
| Article | Year |
|---|---|
Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies.
Topics: Animals; Aqueous Humor; Glaucoma; Hydrogen Sulfide; Intraocular Pressure; Mammals; Retinal Ganglion | 2022 |
Hydrogen sulfide: a gaseous signaling molecule modulates tissue homeostasis: implications in ophthalmic diseases.
Topics: Animals; Blood-Retinal Barrier; Cyclic AMP; Diabetic Retinopathy; Glaucoma; Glycation End Products, | 2019 |
Carbon monoxide and the eye: Implications for glaucoma therapy.
Topics: Animals; Carbon Monoxide; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclini | 2011 |
8 other studies available for hydrogen sulfide and Glaucoma
| Article | Year |
|---|---|
Hydrogen sulfide supplement preserves mitochondrial function of retinal ganglion cell in a rat glaucoma model.
Topics: Animals; Cytochromes c; Disease Models, Animal; Glaucoma; Hydrogen Sulfide; Mitochondria; Neurodegen | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H
Topics: Antiglaucoma Agents; Betaxolol; Gasotransmitters; Glaucoma; Humans; Hydrogen Sulfide | 2022 |
Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma.
Topics: Animals; Autophagy; Blotting, Western; Cell Survival; Flavonoids; Glaucoma; Hydrogen Sulfide; In Sit | 2019 |
Analysis of Plasma Hydrogen Sulfide, Homocysteine, and L-Cysteine in Open-Angle Glaucoma Patients.
Topics: Adult; Aged; Area Under Curve; Case-Control Studies; China; Cysteine; Fasting; Female; Glaucoma; Gla | 2020 |
Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
Topics: Animals; Disease Models, Animal; Female; Glaucoma; Hydrogen Peroxide; Hydrogen Sulfide; Hydrostatic | 2017 |
Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma.
Topics: Animals; Apoptosis; Autophagy; Disease Models, Animal; Glaucoma; Hydrogen Sulfide; Male; Mitochondri | 2018 |
Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model.
Topics: Animals; Cell Survival; Cells, Cultured; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Dis | 2017 |
New prostaglandin derivative for glaucoma treatment.
Topics: Animals; Chemistry, Pharmaceutical; Drug Design; Eye Diseases; Glaucoma; Glutathione; Hydrogen Sulfi | 2009 |